Jessica Klass joined BioMarin in 2018 to lead their advocacy efforts in the US, for their investigational gene therapy program in hemophilia A. program. She comes from a background working in hemophilia for the past 18 years. This time included working for an advocacy organization and another manufacturer in the hemophilia space. She resides in Phoenix with her husband and two children ages 5 and 2.